About RhineGene Germany GmbH
RhineGene Germany GmbH, established in 2023, expands RhineGene’s presence in Europe by delivering high-quality molecular diagnostics solutions to clinical, research, and public-health laboratories. The company provides Real-Time PCR kits, nucleic acid extraction kits, rapid antigen test kits, automated extraction systems, and PCR instrumentation designed to support reliable and efficient diagnostics in line with EU IVDR standards.
As part of the RhineGene group and a subsidiary of Anatolia Geneworks, a leading manufacturer certified under ISO 9001:2015, ISO 13485:2016, and EU IVDR 2017/746, RhineGene Germany benefits from strong R&D capabilities, advanced production expertise, and a global network dedicated to improving patient care and public health.
RhineGene Germany GmbH